Skip to content
Nifurtimox
Lampit (nifurtimox) is a small molecule pharmaceutical. Nifurtimox was first approved as Lampit on 2020-08-06.
Download report
Favorite
FDA Novel Drug Approvals 2020
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Lampit
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Nifurtimox
Tradename
Company
Number
Date
Products
LAMPITBayerN-213464 RX2020-08-06
2 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
lampitNew Drug Application2020-09-04
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
Expiration
Code
NIFURTIMOX, LAMPIT, BAYER HEALTHCARE
2027-08-06ODE-319
2025-08-06NCE
Patent Expiration
No data
ATC Codes
P: Antiparasitic products, insecticides and repellents
— P01: Antiprotozoals
— P01C: Agents against leishmaniasis and trypanosomiasis
— P01CC: Nitrofuran derivatives, antiprotozoal drugs
— P01CC01: Nifurtimox
HCPCS
No data
Clinical
Clinical Trials
17 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
African trypanosomiasisD014353B56—241—5
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Chagas diseaseD014355EFO_0008559B57422—29
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeuroblastomaD009447EFO_000062111———2
MedulloblastomaD008527—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Therapeutic equivalencyD0138101————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameNIFURTIMOX
INNnifurtimox
Description
Nifurtimox is a nitrofuran antibiotic.
Classification
Small molecule
Drug class5-nitrofuran derivatives
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC1CS(=O)(=O)CCN1/N=C/c1ccc([N+](=O)[O-])o1
Identifiers
PDB—
CAS-ID23256-30-6
RxCUI7421
ChEMBL IDCHEMBL290960
ChEBI ID7566
PubChem CID6842999
DrugBankDB11820
UNII IDM84I3K7C2O (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 2,591 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details